MT Pharma
ActiveSummary
The computed 12-month bankruptcy probability of MT Pharma is 3.1% (moderate). The 2025 annual accounts show negative equity (€-48k) and a net result of €-34k. Its solvency ranks better than 11% of 10407 sector peers (fiscal year 2025). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes · tick = 2024
Profitability27▲+18
Solvency18▼-5
Growth58
Track record94
Bankruptcy probability, 12 months
3.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.42 against 0.68 in 2024; short-term debt: 41.8% and cash: 1.3% of total assets), and equity is negative.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-6.9%
Return on assets
-4.9%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
2425
2024 to 2025 · latest year €-48k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
7 d early
2024
on the day
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-34k▲ 37.5%
2024 · €-54k
2024: €-54k
2025: €-34k▲ +37.5% vs 2024
2024 → 2025
Working capital
€-168k▼ 131%
2024 · €-73k
2024: €-73k
2025: €-168k▼ -131% vs 2024
2024 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€-14k-€-48k▼ 240%
2024: €-14k
2025: €-48k▼ -240% vs 2024
Operating result€-34k-€-13k▲ 63.0%
2024: €-34k
2025: €-13k▲ +63.0% vs 2024
Net result€-54k-€-34k▲ 37.5%
2024: €-54k
2025: €-34k▲ +37.5% vs 2024
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €13k in 2025 against €34k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €697k
Fixed assets
€574k ▲ 3.1%
Current assets
€124k ▼ 18.6%
Key figures and ratios
EBITDA
€35k▲
2024 · €-5k
Cash flow
€14k▲
2024 · €-25k
Solvency
-6.9%▼
2024 · -2.0%
Current ratio
0.42▼
2024 · 0.68
Quick ratio
0.20▼
2024 · 0.36
Debt to equity
-15.55▲
2024 · -51.21
ROA
-4.9%▲
2024 · -7.6%
Interest coverage
1.67▲
2024 · -0.26
Debt
€745k▲
2024 · €723k
Debt ≤ 1 year
€291k▲
2024 · €224k
Debt > 1 year
€454k▼
2024 · €498k
Income taxes
€448▲
2024 · €24
Staff costs
€80k▲
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet
Code20242025
Assets
Total assets20/58€708k€697k▼
Fixed assets21/28€557k€574k▲
Intangible fixed assets21€36k€32k▼
Tangible fixed assets22/27€521k€541k▲
Land and buildings22€260k€252k▼
Plant, machinery and equipment23€242k€276k▲
Furniture and vehicles24€18k€14k▼
Current assets29/58€152k€124k▼
Stocks and contracts in progress3€71k€67k▼
Stocks30/36€71k€67k▼
Amounts receivable within one year40/41€27k€45k▲
Trade receivables40€20k€45k▲
Other amounts receivable41€6k-
Cash at bank and in hand54/58€52k€9k▼
Deferred charges and accrued income490/1€2k€2k▲
Equity and liabilities
Total equity and liabilities10/49€708k€697k▼
Equity10/15€-14k€-48k▼
Contributions10/11€40k€40k=
Profit (loss) carried forward14€-54k€-88k▼
Amounts payable17/49€723k€745k▲
Amounts payable after more than one year17€498k€454k▼
Financial debts170/4€498k€454k▼
Amounts payable within one year42/48€224k€291k▲
Current portion of amounts payable after more than one year42€48k€45k▼
Trade debts44€115k€138k▲
Suppliers440/4€115k€138k▲
Taxes, remuneration and social security45€13k€14k▲
Taxes450/3€4k€6k▲
Remuneration and social security454/9€9k€8k▼
Other amounts payable47/48€48k€95k▲
Accrued charges and deferred income492/3€120-
Income statement
Code20242025
Remuneration, social security and pensions62€41k€80k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29k€47k▲
Other operating charges640/8€2k€2k▼
Gross operating margin9900€38k€117k▲
Operating profit (loss)9901€-34k€-13k▲
Financial income75/76B€88€0▼
Recurring financial income75€88€0▼
Financial charges65/66B€20k€21k▲
Recurring financial charges65€20k€21k▲
Profit (loss) for the period before taxes9903€-54k€-33k▲
Income taxes67/77€24€448▲
Profit (loss) for the period9904€-54k€-34k▲
Profit (loss) for the period to be appropriated9905€-54k€-34k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-54k€-88k▼
Profit (loss) brought forward from the previous period14P-€-54k
Social balance
Average headcount (FTE)90871.61.0▼
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Remuneration, social security and pensions62 | €41k | €80k | ▲ 96.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29k | €47k | ▲ 64.7% |
| Other operating charges640/8 | €2k | €2k | ▼ 21.0% |
| Gross operating margin9900 | €38k | €117k | ▲ 209% |
| Operating profit (loss)9901 | €-34k | €-13k | ▲ 63.0% |
| Financial income75/76B | €88 | €0 | ▼ 99.5% |
| Recurring financial income75 | €88 | €0 | ▼ 99.5% |
| Financial charges65/66B | €20k | €21k | ▲ 3.1% |
| Recurring financial charges65 | €20k | €21k | ▲ 3.1% |
| Profit (loss) for the period before taxes9903 | €-54k | €-33k | ▲ 38.3% |
| Income taxes67/77 | €24 | €448 | ▲ 1,796% |
| Profit (loss) for the period9904 | €-54k | €-34k | ▲ 37.5% |
| Profit (loss) for the period to be appropriated9905 | €-54k | €-34k | ▲ 37.5% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €708k | €697k | ▼ 1.6% |
| Fixed assets21/28 | €557k | €574k | ▲ 3.1% |
| Intangible fixed assets21 | €36k | €32k | ▼ 10.3% |
| Tangible fixed assets22/27 | €521k | €541k | ▲ 4.0% |
| Land and buildings22 | €260k | €252k | ▼ 3.3% |
| Plant, machinery and equipment23 | €242k | €276k | ▲ 14.0% |
| Furniture and vehicles24 | €18k | €14k | ▼ 25.0% |
| Current assets29/58 | €152k | €124k | ▼ 18.6% |
| Stocks and contracts in progress3 | €71k | €67k | ▼ 6.1% |
| Stocks30/36 | €71k | €67k | ▼ 6.1% |
| Amounts receivable within one year40/41 | €27k | €45k | ▲ 70.4% |
| Trade receivables40 | €20k | €45k | ▲ 125% |
| Other amounts receivable41 | €6k | - | - |
| Cash at bank and in hand54/58 | €52k | €9k | ▼ 82.0% |
| Deferred charges and accrued income490/1 | €2k | €2k | ▲ 5.2% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €708k | €697k | ▼ 1.6% |
| Equity10/15 | €-14k | €-48k | ▼ 240% |
| Contributions10/11 | €40k | €40k | = |
| Profit (loss) carried forward14 | €-54k | €-88k | ▼ 62.5% |
| Amounts payable17/49 | €723k | €745k | ▲ 3.2% |
| Amounts payable after more than one year17 | €498k | €454k | ▼ 8.9% |
| Financial debts170/4 | €498k | €454k | ▼ 8.9% |
| Amounts payable within one year42/48 | €224k | €291k | ▲ 29.9% |
| Current portion of amounts payable after more than one year42 | €48k | €45k | ▼ 7.0% |
| Trade debts44 | €115k | €138k | ▲ 19.5% |
| Suppliers440/4 | €115k | €138k | ▲ 19.5% |
| Taxes, remuneration and social security45 | €13k | €14k | ▲ 8.2% |
| Taxes450/3 | €4k | €6k | ▲ 49.3% |
| Remuneration and social security454/9 | €9k | €8k | ▼ 11.6% |
| Other amounts payable47/48 | €48k | €95k | ▲ 97.8% |
| Accrued charges and deferred income492/3 | €120 | - | - |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €-54k | €-34k | ▲ 37.5% |
| + Depreciation and write-downs630 | €29k | €47k | ▲ 64.7% |
| Operating cash flow (approximation) | €-25k | €14k | ▲ 153% |
| Investment in fixed assets (approximation) | - | €-64k | - |
| Change in cash | - | €-43k | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Léglise · 1 establishment unit since 2024
Ground area
1,284 m²
Building footprint
194 m²
Volume, LiDAR
1,404 m³
2 parcels, Wallonia · tallest building 10.5 m, ±3 floors. Linked by address, not a title deed.
4
companies at this address
See who is registered here
1 establishment unit
Rue de la Révision 104, 4032 Liège
since 20242.351.501.714
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 84001A1172/00B000 | Wallonia | 1,178 m² | 1 · 107 m² | 7.7 m · 2 fl. |
| 62023B0215/00N003 | Wallonia | 106 m² | 1 · 87 m² | 10.5 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Société Pharmaceutique belge
BE 0403.080.233
Sint-Gillis (bij-Brussel) · FTE 1
Apotheek Holvoet
BE 0404.002.129
Antwerpen · FTE 1
Pharmacie de Péronnes
BE 0406.159.586
Binche · FTE 1
Apotheek Kastel
BE 0406.281.827
Kasterlee · FTE 1
APOTEEK MOMMAERT
BE 0414.393.205
Beersel · FTE 1
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 2,282 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded19-09-2023
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.